Literature DB >> 2903838

Skeletal tissue and transforming growth factor beta.

M Centrella1, T L McCarthy, E Canalis.   

Abstract

Normal skeletal growth results from a balance between the processes of bone matrix synthesis and resorption. These activities are regulated by both systemic and local factors. Bone turnover is dynamic, and skeletal growth must be maintained throughout life. Although many growth promoters are associated with bone matrix, it is enriched particularly with transforming growth factor beta (TGF-beta) activity. Experimental evidence indicates that TGF-beta regulates replication and differentiation of mesenchymal precursor cells, chondrocytes, osteoblasts, and osteoclasts. Recent studies further suggest that TGF-beta activity in skeletal tissue may be controlled at multiple levels by other local and systemic agents. Consequently, the intricate mechanisms by which TGF-beta regulates bone formation are likely to be fundamental to understanding the processes of skeletal growth during development, maintenance of bone mass in adult life, and healing subsequent to bone fracture.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903838     DOI: 10.1096/fasebj.2.15.2903838

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  23 in total

Review 1.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

Review 2.  Vitronectin receptor: tissue specific expression or adaptation to culture?

Authors:  M Horton
Journal:  Int J Exp Pathol       Date:  1990-10       Impact factor: 1.925

Review 3.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

Review 4.  Fibrodysplasia ossificans progressiva: a clue from the fly?

Authors:  F S Kaplan; J A Tabas; M A Zasloff
Journal:  Calcif Tissue Int       Date:  1990-08       Impact factor: 4.333

5.  TGF-β1 impairs mechanosensation of human osteoblasts via HDAC6-mediated shortening and distortion of primary cilia.

Authors:  Sabrina Ehnert; Vrinda Sreekumar; Romina H Aspera-Werz; Sahar O Sajadian; Elke Wintermeyer; Gunther H Sandmann; Christian Bahrs; Jan G Hengstler; Patricio Godoy; Andreas K Nussler
Journal:  J Mol Med (Berl)       Date:  2017-03-07       Impact factor: 4.599

6.  Reinforcing targeted therapeutics with phenotypic stability factors.

Authors:  Paul Yaswen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

8.  Platelet derived growth factor stimulates chondrocyte proliferation but prevents endochondral maturation.

Authors:  K Kieswetter; Z Schwartz; M Alderete; D D Dean; B D Boyan
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

Review 9.  Mechanisms involved in the metastasis of cancer to bone.

Authors:  F W Orr; P Kostenuik; O H Sanchez-Sweatman; G Singh
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.